Front Neurosci 2018;12:301.ArticlePubMedPMC 67
You eat less because you feel satisfied sooner and for longer
GLP-1 receptor agonists such as semaglutide can help manage blood glucose, body weight, and certain cardiometabolic risks when prescribed for an appropriate patient
External resources Tirzepatide-induced gastrointestinal manifestations: a systematic review and meta-analysis (PMC) Effects of GLP-1 receptor agonist on changes in the gut bacterium (Scientific Reports) For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Emerging trends and hot topics in the application of multi-omics in drug discovery: a bibliometric and visualized study
Among them, GLP-1 and GIP (gastric inhibitory polypeptide) are known as incretins, gut-derived hormones that enhance glucose-dependent insulin secretion, playing a pivotal role in maintaining glucose homeostasis and serve as important therapeutic targets for type 2 diabetes and obesity
)
